UMANICK has been Selected to Join the FIWARE Accelerator VIP Programme

UMANICK has been selected among over 800 European start-ups from different sectors belonging to FIWARE Accelerator to enter its VIP Programme. UMANICK entered the eHealth accelerator of the European Commission, FICHe (Future Internet Challenge eHealth), in January 2015. FICHe is one of 16 FIWARE accelerators operating in different areas, being the only one dedicated to health.

In late 2015, the FI-PPP (The Future Internet Public Private Partnership) introduced the FIWARE Accelerator VIP Programme. It is a set of specific actions to give special support to a small number of emerging companies identified by FI-PPP advisers as businesses with great business development, innovation and internationalization potential.

Of the 100 start-ups that were eligible to join the VIP Programme, only 15 were selected. Two of these selected companies, among which is UMANICK, belong to FICHe and are Spanish.

"13% of the companies in the VIP Programme belong to FICHe, representing 6% of all existing FIWARE accelerators. A real success for FICHe. The two FICHe companies chosen are Spanish and are currently being supported by the Murcia Health Service for its 'Living Lab'. This shows that the Murcia Health Service is doing an excellent job promoting information technology in health," has highlighted Emilio Gallego, CEO of UMANICK.

Specifically, UMANICK is carrying just a pilot project for safe patient identification using biometric technologies in the Onco-Hematology Day Hospital of the University Hospital Virgen de la Arrixaca, in Murcia. In the words of Gorka Sanchez Nanclares, Responsible for Innovation at Murcia Health Service: "The pilot has been successful in regards to acceptance, both among professionals, who have incorporated the fingerprint and iris verification to their usual practice, and among patients, who have mostly chosen this access path versus the usual, in the voluntary approach offered to them within this FICHe research project, part of the Murcia Health Service's 'Living Lab'."

The other start-ups selected for the VIP Programme are: Zebra (Belgium), AlzhUp (Spain), Intoino (Italy), Measurence (Italy), Donkey Republic (Denmark), Ususty (Hungary), Parcellab (Germany), OEEX (Germany), Urbi (Germany), Neuroathome (Spain), Everimpact (France), Sensape (Germany), InReception (Italy) and Leeluu (Finland).

All these start-ups will participate together with UMANICK in a Bootcamp with specialised investors that will take place from the 4th to the 6th of May in Milan.

About UMANICK
At UMANICK we are committed with the safety of persons and organizations. Our biometric software with fingerprint, face, voice and iris recognition, allows people to identify themselves in an easy and secure way. Something impossible with the traditional methods of cards and passwords.

Our main mission is to safeguard patient safety in the healthcare sector. Our solutions avoid patient harm stemming from identification errors in healthcare processes at hospitals and medical centres. We also eliminate fraud by patient identity theft, reduce healthcare spending, and improve the image and reputation of the hospital.

Other sectors that benefit from our secure identification biometric systems are Banking and means of payment, Public Administration and Education.

More information on www.umanick.com

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...